Takeda Pharmaceutical Company Limited
武田薬品工業株式会社
Ticker: 4502 · Updated Jun 17, 2026 15:34
Last Updated
Jun 17, 2026 15:34
Period:
Display Units:
Figures:
¥ billions · Annual
Tip: select a row to chart its trend.
Income Statement
Income Statement IFRS Consolidated | FY2016 Mar 31, 2017 Summary only | FY2017 Mar 31, 2018 Summary only | FY2018 Mar 31, 2019 Restated later | FY2019 Mar 31, 2020 | FY2020 Mar 31, 2021 | FY2021 Mar 31, 2022 | FY2022 Mar 31, 2023 | FY2023 Mar 31, 2024 | FY2024 Mar 31, 2025 | FY2025 Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1,732 | 1,771 | 2,097 | 3,291 | 3,198 | 3,569 | 4,027 | 4,264 | 4,582 | 4,506 | |
YoY Change | Not available | 2.2% | 18.5% | 56.9% | -2.8% | 11.6% | 12.8% | 5.9% | 7.5% | -1.7% |
| Not available | Not available | 660 (Restated in the FY2019 report: 652) | 1,090 | 994 | 1,107 | 1,244 | 1,427 | 1,580 | 1,572 | |
| Not available | Not available | 718 | 965 | 876 | 886 | 997 | 1,054 | 1,105 | 1,084 | |
| Not available | Not available | 159.9 | 60.2 | 318.0 | 43.1 | 25.4 | 19.4 | 26.2 | 24.7 | |
| Not available | Not available | 103.2 | 248.7 | 258.9 | 159.1 | 145.2 | 206.5 | 206.7 | 559.0 | |
| Not available | Not available | 205.0 (Restated in the FY2019 report: 237.7) | 100.4 | 509.3 | 460.8 | 490.5 | 214.1 | 342.6 | 6.2 | |
YoY Change | Not available | Not available | Not available | -57.8% | 407.2% | -9.5% | 6.4% | -56.4% | 60.0% | -98.2% |
| Not available | Not available | 16.8 | 27.8 | 105.5 | 23.7 | 62.9 | 52.1 | 46.5 | 211.2 | |
| Not available | Not available | 83.3 | 165.0 | 248.6 | 166.6 | 169.7 | 219.9 | 210.1 | 357.6 | |
| 143.3 | 217.2 | 94.9 (Restated in the FY2019 report: 127.6) | -60.8 | 366.2 | 302.6 | 375.1 | 52.8 | 175.1 | -142.4 | |
| -14.1 (Restated in the FY2019 report: -7.5) | -105.0 | -9.9 | 72.4 | 58.1 | -91.4 | 66.9 | 9.8 | |||
| 115.5 | 186.7 | 109.0 (Restated in the FY2019 report: 135.1) | 44.3 | 376.2 | 230.2 | 317.0 | 144.2 | 108.1 | -152.1 | |
| -9.8 (Restated in the FY2019 report: -13.5) | -243.7 | 321.2 | 594.3 | 594.5 | 995.0 | -165.8 | 932.4 | |||
| 93 | 243 | 99 (Restated in the FY2019 report: 122) | -199 | 697 | 824 | 912 | 1,139 | -58 | 780 |
Notes
- Figures in ¥ billions
- Financial data sourced from official Japanese regulatory disclosures
- Each column header links to its source filing; select a line to see its XBRL elements.
- Each year is shown as filed in that year's own report. Switch to Restated to see a year as the next year's report restated it; restated cells are marked R.
- Displaying 10 of 10 periods
- YoY Change compares each period with the same period a year earlier. A full year's change uses the prior year as that year's own report restates it (cells marked R), so it can differ from the change between the two columns as filed.
- Columns marked “Summary only”: for these years the filing tags only its summary of key figures (主要な経営指標等) in machine-readable form, as is usual for US-GAAP filers, so line items such as operating income are not available. The figures shown are the company’s own consolidated totals.
- FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
Get this data via the API
curl https://hachiquant.com/api/v1/companies/4502/income-statements?view=canonical curl https://hachiquant.com/api/v1/companies/4502/metrics No key needed. API reference